Servizi
CANSON CAPITAL PARTNERS ACTS AS LEAD FINANCIAL ADVISOR TO CAPVEST ON ITS ACQUISITION OF STADA AND CO-INVESTS VIA ITS MERCHANT BANKING ARM
Founded in 1895, STADA is a leading pan-European pharmaceutical company with strong market positions across Consumer Health, Generics, and Specialty Medicines. STADA's products are sold in over 110 countries, with a primary focus on Europe , Eurasia, and Emerging Markets. The company operates with fully integrated capabilities across development, procurement, manufacturing, and commercialisation. In FY24, STADA generated revenues in excess of €4 billion.
As an exceptional healthcare investor with a proven value-creation playbook, CapVest is well positioned to accelerate STADA's next phase of growth by partnering with its management team to strengthen market leadership and drive expansion through innovation, in-licensing, and M&A.
This transaction further reinforces Canson's partnership approach to unlocking opportunities:
The transaction reinforces Canson's expertise in healthcare and strengthens our distinctive position in Consumer Health, a focus initiated through our partnership with Alan Main and since expanded through involvement in numerous sector-defining transactions.
As a key partner to CapVest, Canson will have the ability to co-invest in the transaction through its merchant banking arm. This marks our second healthcare investment following Chanelle Pharma in 2024. Canson has previously co-invested in several landmark private equity transactions, including the acquisition of minority stakes in Refinitiv (Thomson Reuters' Financial and Risk division); Kantar (WPP's data, research and analytics business); INWIT ( Italy's largest mobile tower operator); Fedrigoni (global producer of premium labels and packaging) and Chanelle Pharma (leading Irish animal health company).
The STADA transaction is the sixth partnership where Canson has both advised and co-invested since our inception. This aligns with Canson's merchant banking model, connecting alternative sources of capital with unique investment opportunities. Canson has been involved in over $80 billion in Enterprise Value of PE-related transactions and has managed over $500 million in aggregate AUM across its merchant banking funds.
In a joint statement, the Canson deal team said:
said
Canson Capital Partners is a leading Alternative Capital-focused Specialist Investment and Merchant Banking firm. Providing principal-to-principal engagement, the team seeks to connect sources of Alternative Capital with specific opportunities, enabling clients to achieve their long-term strategic objectives. Founded in 2017, Canson Capital Partners has managed assets of over $500 million and advised on private equity-related transactions with an aggregate Enterprise Value of over $80 billion . Canson Capital Partners is the trading name of Canson Ltd, which is authorised and regulated by the Financial Conduct Authority.
Georgina Hunt
info@cansoncp.com
Logo - https://mma.prnewswire.com/media/2761963/Canson_Capital_Partners_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/canson-capital-partners-acts-as-lead-financial-advisor-to-capvest-on-its-acquisition-of-stada-and-co-invests-via-its-merchant-banking-arm-302543201.html